Prospective Follow-Up Observational Study to Examine the Progression of ADHD Drug Treatment and to Analyze Associated Factors
Phase of Trial: Phase IV
Latest Information Update: 19 Jun 2015
At a glance
- Drugs Methylphenidate (Primary) ; Atomoxetine
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Janssen
- 30 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Dec 2013 Planned end date changed from 1 Mar 2014 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 05 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.